Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Pharmacogenomic predictor of long-term residual chemotherapy-induced peripheral neuropathy in ovarian cancer survivors: A substudy of the GINECO Vivrovaire study.
Gynecol Oncol. 2024 May 21;187:139-144. doi: 10.1016/j.ygyno.2024.04.021. Online ahead of print.
Gynecol Oncol. 2024.
PMID: 38776631
Bevacizumab, olaparib, and durvalumab in patients with relapsed ovarian cancer: a phase II clinical trial from the GINECO group.
Freyer G, Floquet A, Tredan O, Carrot A, Langlois-Jacques C, Lopez J, Selle F, Abdeddaim C, Leary A, Dubot-Poitelon C, Fabbro M, Gladieff L, Lamuraglia M.
Freyer G, et al. Among authors: dubot poitelon c.
Nat Commun. 2024 Mar 5;15(1):1985. doi: 10.1038/s41467-024-45974-w.
Nat Commun. 2024.
PMID: 38443333
Free PMC article.
Clinical Trial.
Item in Clipboard
Impact of web application support versus standard management on adherence with adjuvant hormone therapy in patients treated for breast cancer: the WEBAPPAC study.
Gernier F, Grellard JM, Dupont C, Castel H, Fernette M, Lahaye F, Charles RM, Leroux T, Ory C, Faveyrial A, Morel A, Emile G, Levy C, Segura C, Allouache D, Johnson A, Geffrelot J, Gunzer K, Lelaidier A, Girault G, Dubot-Poitelon C, San C, Lequesne J, Clarisse B.
Gernier F, et al. Among authors: dubot poitelon c.
BMC Cancer. 2023 Aug 9;23(1):736. doi: 10.1186/s12885-023-11242-1.
BMC Cancer. 2023.
PMID: 37559004
Free PMC article.
Clinical Trial.
Item in Clipboard
Pretreatment neutrophil to lymphocyte ratio as prognostic factor in metastatic breast cancer treated with cyclin dependent kinase 4/6 inhibitors.
Rottier P, Emile G, Johnson A, Levy C, Allouache D, Hrab I, Segura C, Morel A, Villemin M, Dubot-Poitelon C, Boismoreau L, Cherifi F, Lequesne J, Da Silva A.
Rottier P, et al. Among authors: dubot poitelon c.
Front Oncol. 2023 Jan 19;12:1105587. doi: 10.3389/fonc.2022.1105587. eCollection 2022.
Front Oncol. 2023.
PMID: 36741710
Free PMC article.
Item in Clipboard
HELENA: HER2-Low as a prEdictive factor of response to Neoadjuvant chemotherapy in eArly breast cancer.
Cherifi F, Da Silva A, Johnson A, Blanc-Fournier C, Abramovici O, Broyelle A, Levy C, Allouache D, Hrab I, Segura C, Morel A, Villemin M, Boscher C, Dubot-Poitelon C, Rottier P, Lequesne J, Emile G.
Cherifi F, et al. Among authors: dubot poitelon c.
BMC Cancer. 2022 Oct 20;22(1):1081. doi: 10.1186/s12885-022-10163-9.
BMC Cancer. 2022.
PMID: 36266623
Free PMC article.
Item in Clipboard
Cite
Cite